NEW YORK (GenomeWeb News) – Definiens today said that it has raised €10 million ($12.9 million) in a private round of financing.

The Munich, Germany-based firm said that it would use the proceeds for commercial expansion of its current business and to develop and commercialize clinical digital pathology products. Its image analysis and data mining tools are used for quantitative digital pathology in life sciences research and for tissue-based diagnostic biomarker development.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.

Jul
25
Sponsored by
Streck

This online seminar will discuss the advantages of incorporating molecular testing into the microbiology laboratory to aid in the identification of relevant antibiotic resistance mechanisms. 

Aug
09
Sponsored by
Agena Bioscience

In this two-part webinar, Dr. Elin Gray, from Edith Cowan University, and Ms. Weiwei Zhao, from Kingmed diagnostic, will compare the highly sensitive, multiplexed UltraSEEK technology, on the MassARRAY system, to digital droplet PCR (ddPCR) results on melanoma and non-small cell lung carcinoma samples.

Aug
20
Sponsored by
Canon BioMedical

This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.

Aug
27
Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.